Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences

Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences


While the biotechnology industry has had a rough time so far this year, three of the leading players may be hoping to turn things around when they take their turns in the earnings spotlight this week. The consensus Wall Street forecasts indicate that analysts have high hopes for solid to strong results from Amgen, Inc. and Celgene Corporation , on both the top and bottom lines .



from Biotech News